<DOC>
	<DOCNO>NCT00667992</DOCNO>
	<brief_summary>This study carry see budesonide HFA effective , safe well tolerate compare budesonide CFC . Budesonide HFA already give research study , healthy volunteer subject asthma .</brief_summary>
	<brief_title>Study Comparing Budesonide Hydrofluoroalkane ( HFA ) v Chlorofluorocarbon ( CFC ) Pressurized Metered Dose Inhalers ( pMDI ) Patients With Mild Moderate Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Patients suffer stable , persistent , mild moderate asthma define Global Initiative Asthma ( GINA ) Guidelines FEV1 &gt; 60 % ICS take ≤ 1000 μg BDP per day , equivalent Methacholine PC20 &lt; 4 mg/mL Known suspect hypersensitivity budesonide constituent budesonide HFA pMDI budesonide CFC pMDI . Currently smoker cease smoking within 6 month Visit 1 . Exacerbations asthma require oral steroid , hospitalisation change asthma therapy previous three month . Diagnosis Chronic Obstructive Pulmonary Disease ( COPD ) bronchiectasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Asthma hyperreactivity</keyword>
</DOC>